Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2013 2
2014 2
2015 2
2016 1
2017 3
2018 6
2019 6
2020 5
2021 6
2022 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
Development and Functional Characterization of a Versatile Radio-/Immunotheranostic Tool for Prostate Cancer Management.
Arndt C, Bergmann R, Striese F, Merkel K, Máthé D, Loureiro LR, Mitwasi N, Kegler A, Fasslrinner F, González Soto KE, Neuber C, Berndt N, Kovács N, Szöllősi D, Hegedűs N, Tóth G, Emmermann JP, Harikumar KB, Kovacs T, Bachmann M, Feldmann A. Arndt C, et al. Among authors: berndt n. Cancers (Basel). 2022 Apr 14;14(8):1996. doi: 10.3390/cancers14081996. Cancers (Basel). 2022. PMID: 35454902 Free PMC article.
Targeting Acute Myeloid Leukemia Using the RevCAR Platform: A Programmable, Switchable and Combinatorial Strategy.
Kittel-Boselli E, Soto KEG, Loureiro LR, Hoffmann A, Bergmann R, Arndt C, Koristka S, Mitwasi N, Kegler A, Bartsch T, Berndt N, Altmann H, Fasslrinner F, Bornhäuser M, Bachmann MP, Feldmann A. Kittel-Boselli E, et al. Among authors: berndt n. Cancers (Basel). 2021 Sep 24;13(19):4785. doi: 10.3390/cancers13194785. Cancers (Basel). 2021. PMID: 34638268 Free PMC article.
And Yet It Moves: Oxidation of the Nuclear Autoantigen La/SS-B Is the Driving Force for Nucleo-Cytoplasmic Shuttling.
Berndt N, Bippes CC, Michalk I, Bartsch T, Arndt C, Puentes-Cala E, Soto JA, Loureiro LR, Kegler A, Bachmann D, Gross JK, Gross T, Kurien BT, Scofield RH, Farris AD, James JA, Bergmann R, Schmitz M, Feldmann A, Bachmann MP. Berndt N, et al. Int J Mol Sci. 2021 Sep 8;22(18):9699. doi: 10.3390/ijms22189699. Int J Mol Sci. 2021. PMID: 34575862 Free PMC article.
Two Be or Not Two Be: The Nuclear Autoantigen La/SS-B Is Able to Form Dimers and Oligomers in a Redox Dependent Manner.
Berndt N, Bippes CC, Michalk I, Bachmann D, Bachmann J, Puentes-Cala E, Bartsch T, Loureiro LR, Kegler A, Bergmann R, Gross JK, Gross T, Kurien BT, Scofield RH, Farris AD, James JA, Schmitz M, Fahmy K, Feldmann A, Arndt C, Bachmann MP. Berndt N, et al. Int J Mol Sci. 2021 Mar 25;22(7):3377. doi: 10.3390/ijms22073377. Int J Mol Sci. 2021. PMID: 33806091 Free PMC article.
Development of a ghrelin receptor inverse agonist for positron emission tomography.
Bergmann R, Chollet C, Els-Heindl S, Ullrich M, Berndt N, Pietzsch J, Máthé D, Bachmann M, Beck-Sickinger AG. Bergmann R, et al. Among authors: berndt n. Oncotarget. 2021 Mar 2;12(5):450-474. doi: 10.18632/oncotarget.27895. eCollection 2021 Mar 2. Oncotarget. 2021. PMID: 33747360 Free PMC article.
Versatile chimeric antigen receptor platform for controllable and combinatorial T cell therapy.
Feldmann A, Hoffmann A, Bergmann R, Koristka S, Berndt N, Arndt C, Rodrigues Loureiro L, Kittel-Boselli E, Mitwasi N, Kegler A, Lamprecht C, González Soto KE, Bachmann M. Feldmann A, et al. Among authors: berndt n. Oncoimmunology. 2020 Jul 3;9(1):1785608. doi: 10.1080/2162402X.2020.1785608. Oncoimmunology. 2020. PMID: 32923149 Free PMC article.
35 results